Phase 3 oncology trials, per-patient cost (PhRMA 2015, as cited by Health Advances)

$69,000

USD per patient, US

“$69,000 per patient for oncology trials (PhRMA 2015)”

Health Advances, Orphan Drug Development: What are the Real Costs? (10 April 2019; read from an Internet Archive copy), 2019-04

Kind of source

Named press report

Read on

2026-11-06

Daily check

Source re-read on 2026-11-06 needs a browser (PDF or protected page)

What to know

Highest therapeutic area in the cited PhRMA range; infectious disease was the lowest at $18,000.